Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs EPR Properties (EPR) Price & Performance

Amylx Pharmaceuticals IncTrade
EPR PropertiesTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs EPR Properties — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while EPR Properties trades at $59.8 (market cap $4.58B). The key difference: EPR Properties is the larger of the two by market cap, and EPR Properties pays a 6.22% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXEPR
Market Cap
$2.64B$4.58B
Sector
HealthReal Estate
52-Week High
$24.19$64.32
52-Week Low
$7.82$48.71
Enterprise Value
$2.39B$8.09B
Dividend Yield
6.22%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About EPR Properties

EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.

Read more on EPR